103 related articles for article (PubMed ID: 2204019)
1. Target dependence of antisense oligodeoxynucleotide inhibition of c-Ha-ras p21 expression and focus formation in T24-transformed NIH3T3 cells.
Daaka Y; Wickstrom E
Oncogene Res; 1990; 5(4):267-75. PubMed ID: 2204019
[TBL] [Abstract][Full Text] [Related]
2. The antisense c-Ha-ras oligodeoxynucleotides inhibit the proliferation of the gastrocarcinoma-DNA-transformed rat 3-3 cells and reduce the p21 expression of the cells.
Xu Y; Deng GR; Liang YY; Li C
Sci China B; 1991 Jan; 34(1):35-41. PubMed ID: 2015062
[TBL] [Abstract][Full Text] [Related]
3. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
[TBL] [Abstract][Full Text] [Related]
4. Sequence specific inhibition of in vitro translation of mutated or normal ras p21.
Yu ZP; Chen DF; Black RJ; Blake K; Ts'o PO; Miller P; Chang EH
J Exp Pathol; 1989; 4(2):97-108. PubMed ID: 2671311
[TBL] [Abstract][Full Text] [Related]
5. The synthesis and biological activities of oligodeoxynucleotides that are covalently linked to psoralen at their 5' ends.
Wang LX; Yang DC; Lu YY; Takagi Y; Taira K; Li T; Zhang LH
Drug Des Discov; 1995 Nov; 13(2):109-21. PubMed ID: 8872455
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of N-ras oncogene anti-sense, sense and nonsense sequence methylphosphonate oligonucleotide analogues.
Tidd DM; Hawley P; Warenius HM; Gibson I
Anticancer Drug Des; 1988 Aug; 3(2):117-27. PubMed ID: 2457379
[TBL] [Abstract][Full Text] [Related]
7. Walking along human c-myc mRNA with antisense oligodeoxynucleotides: maximum efficacy at the 5' cap region.
Bacon TA; Wickstrom E
Oncogene Res; 1991; 6(1):13-9. PubMed ID: 1997945
[TBL] [Abstract][Full Text] [Related]
8. Comparative inhibition of ras p21 protein synthesis with phosphorus-modified antisense oligonucleotides.
Chang EH; Yu Z; Shinozuka K; Zon G; Wilson WD; Strekowska A
Anticancer Drug Des; 1989 Oct; 4(3):221-32. PubMed ID: 2679622
[TBL] [Abstract][Full Text] [Related]
9. [Inhibitory effect of monoclonal antibody PD4 on Ha-ras transformed cells Rat3-3].
Yin WN
Zhonghua Zhong Liu Za Zhi; 1991 Mar; 13(2):82-6. PubMed ID: 1879298
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of antisense DNA and its derivative on gastric transformed cell carcinogenicity].
Yang D; Li T; Xu W
Zhonghua Wai Ke Za Zhi; 1995 Jan; 33(1):26-8. PubMed ID: 7774440
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
[TBL] [Abstract][Full Text] [Related]
12. Antisense PNA tridecamers targeted to the coding region of Ha-ras mRNA arrest polypeptide chain elongation.
Dias N; Dheur S; Nielsen PE; Gryaznov S; Van Aerschot A; Herdewijn P; Hélène C; Saison-Behmoaras TE
J Mol Biol; 1999 Nov; 294(2):403-16. PubMed ID: 10610767
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effects of malignant phenotype of human bladder cancer cell line by c-Ha-ras, c-myc antisense oligodeoxynucleotide].
Li M; Yu M; Jin F
Zhonghua Wai Ke Za Zhi; 1996 Jan; 34(1):7-9. PubMed ID: 9275677
[TBL] [Abstract][Full Text] [Related]
14. Oligonucleotide treatment of ras-induced tumors in nude mice.
Wickstrom E
Mol Biotechnol; 2001 May; 18(1):35-55. PubMed ID: 11439698
[TBL] [Abstract][Full Text] [Related]
15. Ha-ras and N-ras regulate MAPK activity by distinct mechanisms in vivo.
Hamilton M; Wolfman A
Oncogene; 1998 Mar; 16(11):1417-28. PubMed ID: 9525741
[TBL] [Abstract][Full Text] [Related]
16. Modulation of ras expression by anti-sense, nonionic deoxyoligonucleotide analogs.
Brown D; Yu ZP; Miller P; Blake K; Wei C; Kung HF; Black RJ; Ts'o PO; Chang EH
Oncogene Res; 1989; 4(4):243-52. PubMed ID: 2671865
[TBL] [Abstract][Full Text] [Related]
17. Control of complexity constraints on combinatorial screening for preferred oligonucleotide hybridization sites on structured RNA.
Bruice TW; Lima WF
Biochemistry; 1997 Apr; 36(16):5004-19. PubMed ID: 9125523
[TBL] [Abstract][Full Text] [Related]
18. Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers.
Nagata Y; Abe M; Kobayashi K; Yoshida K; Ishibashi T; Naoe T; Nakayama E; Shiku H
Cancer Res; 1990 Feb; 50(3):480-2. PubMed ID: 2404571
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of chronic myelogenous leukemia cells harboring a BCR-ABL B3A2 junction by antisense oligonucleotides targeted at the B2A2 junction.
Mahon FX; Ripoche J; Pigeonnier V; Jazwiec B; Pigneux A; Moreau JF; Reiffers J
Exp Hematol; 1995 Dec; 23(14):1606-11. PubMed ID: 8542954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
